The Synthesis of BODIPY-TKI Conjugates and Investigation of Their Ability to Target the Epidermal Growth Factor Receptor
Open Access
Abstract
A near-IR BODIPY was covalently conjugated via its isothiocyanate groups to one or two Erlotinib molecules, a known tyrosine kinase inhibitor (TKI), via triethylene glycol spacers, to produce two novel BODIPY-monoTKI and BODIPY-diTKI conjugates. The ability of these conjugates to target the intracellular domain of the epidermal growth factor receptor (EGFR) was investigated using molecular modeling, surface plasma resonance (SPR), EGFR kinase binding assay, time-dependent cellular uptake, and fluorescence microscopy. While both the BODIPY-monoTKI and the BODIPY-diTKI conjugates were shown to bind to the EGFR kinase by SPR and accumulated more efficiently within human HEp2 cells that over-express EGFR than BODIPY alone, only the BODIPY-monoTKI exhibited kinase inhibition activity. This is due to the high hydrophobic character and aggregation behavior of the BODIPY-diTKI in aqueous solutions, as shown by fluorescence quenching. Furthermore, the competition of the two Erlotinibs in the diTKI conjugate for the active site of the kinase, as suggested by computational modeling, might lead to a decrease in binding relative to the monoTKI conjugate. Nevertheless, the efficient cellular uptake and intracellular localization of both conjugates with no observed cytotoxicity suggest that both could be used as near-IR fluorescent markers for cells that over-express EGFR.Keywords
Funding Information
- National Science Foundation (CHE-2055190, 5R01CA255176)
- National Institutes of Health (CHE-2055190, 5R01CA255176)
This publication has 23 references indexed in Scilit:
- Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agentsFuture Journal of Pharmaceutical Sciences, 2016
- Advances in the Early Detection of Lung Cancer using Analysis of Volatile Organic Compounds: From Imaging to SensorsAsian Pacific Journal of Cancer Prevention, 2014
- Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosisChemical Communications, 2013
- Synthesis and cellular properties of Near-IR BODIPY–PEG and carbohydrate conjugatesTetrahedron, 2013
- Synthesis, characterization, screening and docking analysis of 4-anilinoquinazoline derivatives as tyrosine kinase inhibitorsEuropean Journal of Medicinal Chemistry, 2013
- Synthesis and characterization of rhenium and technetium-99m tricarbonyl complexes bearing the 4-[3-bromophenyl]quinazoline moiety as a biomarker for EGFR-TK imagingEuropean Journal of Medicinal Chemistry, 2009
- Syntheses and Properties of a Series of Cationic Water-Soluble PhthalocyaninesJournal of Medicinal Chemistry, 2008
- BODIPY Dyes and Their Derivatives: Syntheses and Spectroscopic PropertiesChemical Reviews, 2007
- Palladium‐Catalyzed Coupling Reactions for the Functionalization of BODIPY Dyes with Fluorescence Spanning the Visible SpectrumEuropean Journal of Organic Chemistry, 2006
- Epidermal growth factor receptor (EGFR) signaling in cancerGene, 2006